Oslo, Norway

Nykode Therapeutics Asa


USPTO Granted Patents = 7


Trademarks = 1

Forward Citations = 1

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal Agnete Brunsvik Fredriksen (6 out of 12 patents)

silverMedal Bjarne Bogen (4 out of 16 patents)

bronzeMedal Pier Adelchi Ruffini (2 out of 4 patents)

4.  Gunnveig Grodeland (2 out of 2 patents)

5.  Monika Sekelja (1 out of 5 patents)

6.  Karoline Schjetne (1 out of 3 patents)

7.  Stine Granum (1 out of 3 patents)

8.  Elisabeth Stubsrud (1 out of 2 patents)

9.  Jeroen Van Bergen (1 out of 1 patent)

10.  Gerben Carolus Martinus Zondag (1 out of 1 patent)

11.  Inger Sandlie (19 patents)


7 patents:

Company Overview
Nykode Therapeutics ASA is a clinical-stage biotechnology company focused on developing innovative immunotherapies for cancer and other diseases. The company utilizes its proprietary technology platform to create personalized therapeutic vaccines that aim to stimulate the immune system to target and destroy cancer cells. Nykode's lead product candidates are designed to address unmet medical needs in oncology, with a commitment to advancing the field of immunotherapy through rigorous clinical development and collaboration with leading research institutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#71 in Oslo

#239 in Norway

Oslo, NO
Oslo, Norway
Forward Citations = 1

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Nykode Therapeutics Asa. Retrieved from https://idiyas.com/company/nykode-therapeutics-asa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…